Human Monoclonal Antibodies as a Countermeasure Against Botulinum Toxins
Brad Kline(University of California, San Francisco), Qimin Chao(Morphotek (United States)), Rina Kennedy, Earl F. Albone(Morphotek (United States)), Luigi Grasso(Morphotek (United States)), Bryon Martinez
Unknown
November 30, 2012
Cited by 0
Related Papers
Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration
|Proceedings of the National Academy of Sciences|2007|153
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology
|Proceedings of the National Academy of Sciences|2006|50
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
|Oncotarget|2015|48
<sup>68</sup>Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with<sup>18</sup>F-FDG
|Journal of Nuclear Medicine|2024|36
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
|Journal of Immune Based Therapies and Vaccines|2010|31